Sara Dishon

878 total citations
20 papers, 676 citations indexed

About

Sara Dishon is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Sara Dishon has authored 20 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 10 papers in Genetics and 4 papers in Oncology. Recurrent topics in Sara Dishon's work include BRCA gene mutations in cancer (9 papers), Multiple Sclerosis Research Studies (9 papers) and Nutrition, Genetics, and Disease (3 papers). Sara Dishon is often cited by papers focused on BRCA gene mutations in cancer (9 papers), Multiple Sclerosis Research Studies (9 papers) and Nutrition, Genetics, and Disease (3 papers). Sara Dishon collaborates with scholars based in Israel, United States and Spain. Sara Dishon's co-authors include Ariel Miller, Daniel Golan, Gad Rennert, Idit Lavi, Eli Somer, Elsebeth Staun-Ram, Mira Barak, Sophia Ish‐Shalom, Lea Glass‐Marmor and Orit Rozenberg and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Sara Dishon

20 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Dishon Israel 12 466 111 99 65 65 20 676
N. Koch–Henriksen Denmark 12 542 1.2× 29 0.3× 99 1.0× 120 1.8× 91 1.4× 15 714
David Rintell United States 14 441 0.9× 15 0.1× 114 1.2× 102 1.6× 55 0.8× 23 633
Tsegaye Tewelde Gebrehiwot Ethiopia 6 493 1.1× 18 0.2× 78 0.8× 96 1.5× 57 0.9× 8 838
Marta Elian United Kingdom 18 440 0.9× 103 0.9× 104 1.1× 235 3.6× 40 0.6× 50 959
Andrea Werdecker Germany 2 493 1.1× 17 0.2× 76 0.8× 96 1.5× 57 0.9× 2 759
D. Buljevac Netherlands 8 635 1.4× 17 0.2× 130 1.3× 134 2.1× 132 2.0× 8 866
Pernilla Stridh Sweden 14 223 0.5× 57 0.5× 27 0.3× 82 1.3× 91 1.4× 40 694
Muhteşem Gedizlioğlu Türkiye 12 177 0.4× 21 0.2× 78 0.8× 59 0.9× 37 0.6× 39 439
Fotini Pittas Australia 15 1.1k 2.3× 32 0.3× 246 2.5× 128 2.0× 143 2.2× 20 1.3k
Kyla A. McKay Sweden 21 1.2k 2.5× 27 0.2× 214 2.2× 287 4.4× 146 2.2× 54 1.5k

Countries citing papers authored by Sara Dishon

Since Specialization
Citations

This map shows the geographic impact of Sara Dishon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Dishon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Dishon more than expected).

Fields of papers citing papers by Sara Dishon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Dishon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Dishon. The network helps show where Sara Dishon may publish in the future.

Co-authorship network of co-authors of Sara Dishon

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Dishon. A scholar is included among the top collaborators of Sara Dishon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Dishon. Sara Dishon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Golan, Daniel, Elsebeth Staun-Ram, Lea Glass‐Marmor, et al.. (2013). The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis. Brain Behavior and Immunity. 32. 180–185. 55 indexed citations
3.
Paperna, Tamar, Izabella Lejbkowicz, Panayiota Petrou, et al.. (2012). Multiple sclerosis in diverse populations: characteristics in distinct Arab ethnicities in Israel. Multiple Sclerosis Journal. 18(12). 1737–1744. 8 indexed citations
4.
Mukherjee, Bhramar, Gad Rennert, Jaeil Ahn, et al.. (2011). High Risk of Colorectal and Endometrial Cancer in Ashkenazi Families With the MSH2 A636P Founder Mutation. Gastroenterology. 140(7). 1919–1926. 11 indexed citations
5.
Burke, Therese, et al.. (2011). The Evolving Role of the Multiple Sclerosis Nurse. International Journal of MS Care. 13(3). 105–112. 17 indexed citations
6.
Lavie, Ofer, Steven A. Narod, Flavio Lejbkowicz, et al.. (2010). Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population. Annals of Oncology. 22(4). 964–966. 42 indexed citations
7.
Lejbkowicz, Izabella, Tamar Paperna, Nili Stein, Sara Dishon, & Ariel Miller. (2010). Internet Usage by Patients with Multiple Sclerosis: Implications to Participatory Medicine and Personalized Healthcare. SHILAP Revista de lepidopterología. 2010. 1–7. 54 indexed citations
8.
Somer, Eli, et al.. (2010). Patients with multiple sclerosis in a war zone: coping strategies associated with reduced risk for relapse. Multiple Sclerosis Journal. 16(4). 463–471. 23 indexed citations
9.
Raskin, Leon, Flavio Lejbkowicz, Ofra Barnett‐Griness, et al.. (2009). BRCA1 Breast Cancer Risk Is Modified by CYP19 Polymorphisms in Ashkenazi Jews. Cancer Epidemiology Biomarkers & Prevention. 18(5). 1617–1623. 11 indexed citations
10.
Lavie, Ofer, Stephen B. Gruber, Flavio Lejbkowicz, Sara Dishon, & Gad Rennert. (2008). Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation. American Journal of Obstetrics and Gynecology. 199(2). 148.e1–148.e3. 6 indexed citations
11.
Golan, Daniel, et al.. (2008). Impact of exposure to war stress on exacerbations of multiple sclerosis. Annals of Neurology. 64(2). 143–148. 53 indexed citations
12.
Raskin, Leon, Ofra Barnett‐Griness, D. Reisfeld, et al.. (2007). BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews. Journal of Clinical Oncology. 25(18_suppl). 10511–10511. 1 indexed citations
13.
Miller, Ariel & Sara Dishon. (2006). Health-related Quality of Life in Multiple Sclerosis: The Impact of Disability, Gender and Employment Status. Quality of Life Research. 15(2). 259–271. 230 indexed citations
14.
Rennert, Gad, Sara Dishon, Hedy S. Rennert, & Fuad Fares. (2005). Differences in the characteristics of families with BRCA1 and BRCA2 mutations in Israel. European Journal of Cancer Prevention. 14(4). 357–361. 11 indexed citations
15.
Miller, Ariel & Sara Dishon. (2005). Health-related quality of life in multiple sclerosis: psychometric analysis of inventories. Multiple Sclerosis Journal. 11(4). 450–458. 43 indexed citations
16.
Hagoel, Lea, Efrat Neter, Sara Dishon, Ofra Barnett, & Gad Rennert. (2003). BRCA1/2 Mutation Carriers: Living with Susceptibility. Public Health Genomics. 6(4). 242–248. 3 indexed citations
17.
Hopwood, Penelope, C. J. van Asperen, Pascale Bourret, et al.. (2003). Cancer Genetics Service Provision: A Comparison of Seven European Centres. Public Health Genomics. 6(4). 192–205. 18 indexed citations
18.
Steinmetz, Dov, et al.. (2001). [Hospital-at-home as a solution for the treatment requirements of acute exacerbation in multiple sclerosis].. PubMed. 140(7). 603–6, 678. 2 indexed citations
19.
Hagoel, Lea, et al.. (2000). Proband family uptake of familial-genetic counselling. Psycho-Oncology. 9(6). 522–527. 21 indexed citations
20.
Hagoel, Lea, et al.. (2000). Proband family uptake of familial‐genetic counselling. Psycho-Oncology. 9(6). 522–527. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026